Navigation Links
Study details cost-effectiveness of rheumatoid arthritis treatments for Medicare recipients
Date:4/14/2008

For elderly and disabled rheumatoid arthritis (RA) sufferers, the Medicare Prescription Drug Improvement and Modernization Act (MMA) brought the promise of better disease management with biologic drugs. Prior to its passage in 2006, Medicare covered only one of the tumor necrosis factor (TNF) inhibitors, the infusion drug infliximab, also known by its brand name, Remicade. Since the MMA, most Medicare prescription drug plans offer coverage of the anti-TNF self-injectables etanercept (Enbrel) and adalimumab (Humira), as well as the interleukin-1 receptor antagonist anakinra (Kineret). More effective at controlling the painful and crippling symptoms of RA than conventional disease-modifying antirheumatic drugs (DMARDs), biologic drugs are also more expensive. According to a recent study, this new class of therapies has increased the cost of treating a patient with RA in the United States 3-fold.

To help Medicare beneficiaries and their providers select the best-value treatment option, a team of researchers, supported by the Agency for Healthcare Research and Quality of the U.S. Department of Health and Human Services, developed a mathematical model to estimate the costs and benefits of etanercept, adalimumab, and anakinra compared with those of infliximab over a patients lifetime. Their results, featured in the April 2008 issue of Arthritis & Rheumatism ( www.interscience.wiley.com/journal/arthritis ), make a case for coverage of either etanercept or adalimumab over infliximab. In terms of effectiveness, the 3 TNF inhibitors are nearly equal. Getting the same results with infliximab, however, requires paying moreroughly $13,000 moreper patient. Anakinra is substantially less costly than the anti-TNF drugs but also less effective.

The researchers drew on data on RA patients from randomized controlled trials and a storehouse of self-reported patient information, the National Data
'/>"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Study sheds light on deadly lung disease
2. NovoCure presents results from breast cancer pilot study
3. Mayo-led study finds smoking related to subset of colorectal cancers
4. National hospice study reveals gaps in service
5. Study Points to New Treatments for Polycystic Kidney Disease
6. MRI better than MDCT in detecting endoleaks, study says
7. Personality study shows risk of first depression episode late in life
8. 3T MRI plays significant role in detecting prostate cancer, study says
9. Study shows doctors offices can help stem abuse of Oxycontin, other narcotic painkillers
10. Quintiles Ranks First in Pan-European Clinical Investigator Study
11. Study Showed Minimally Invasive Surgery Reduced Risk of Hospital-Acquired Infections Compared to Open Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... September 16, 2014 Wholelifeinsurancecompanies.org has released ... find life insurance with a bad heart condition. , ... find affordable life insurance if they compare quotes. Most ... the decision depend on the actual and past medical ... that caused several heart attacks in the past, his ...
(Date:9/16/2014)... positron emission tomography (PET) tracer is effective in diagnosing ... according to a case study conducted at the Icahn ... Neuroimaging (MNI) LLC in New Haven, and published September ... Specifically, the study results suggest that an experimental radiolabeled ... onto a protein called tau that accumulates in the ...
(Date:9/16/2014)... soon better predict a man,s risk of getting prostate ... the largest-ever analysis of the cancer,s genetic biomarkers, reported ... of Health and Biomedical Innovation,s Dr Jyotsna Batra and ... in the large consortia of research hubs around the ... genetic markers in 80,000 men. , "It,s the largest ...
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 ... in diagnosing concussion-related brain disease while a person is ... the Icahn School of Medicine at Mount Sinai, and ... published September 16 in the journal Translational Psychiatry. , ... compound called [18 F]-T807, which is designed to latch ...
(Date:9/16/2014)... 16, 2014 The Muscular Dystrophy ... flu vaccines for individuals affected by muscle disease, ... other neuromuscular diseases. , MDA offers this service ... disease who, because of compromised respiratory function — ... lungs — are at increased risk of serious ...
Breaking Medicine News(10 mins):Health News:No Exam Life Insurance for Clients Who Have a Bad Heart Condition! 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 2Health News:Neuroimaging technique identifies concussion-related brain disease in living brain 3Health News:New gene research helps pinpoint prostate cancer risk 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 2Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 3Health News:Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain 4Health News:MDA Offers Flu Shots to Those Affected by Muscle Disease 2
... and vegetable juice could stave off Alzheimer's disease, say ... in the skin and peels of fruits and vegetables. ... ,Lab trials have earlier shown that polyphenols can ... to significantly delay the onset of serious cognitive impairment. ...
... silent killer worldwide and it is imperative to make people aware ... to be taken, say medical experts.// ,Now in its third ... to increase awareness about hepatitis B and C. The theme for ... silent disease. Most of the people are unaware that they have ...
... economic, social and health factors affecting African Americans, Penn ... Black’//. , ,Dr. Shaun Gabbidon, associate professor of ... and public policy, both at Penn State's Harrisburg campus, ... the Journal of Black Studies. , ,"There are ...
... among eighty countries has found that the Iraqi public portrays ... // out-groups. Ethnic solidarity seems to be at an all ... on restoration of order and security, along with emergence of ... embittered and torn Iraqi nation. The analysis is an outcome ...
... starches and sugars with unhealthy high-fat foods? A new ... ,A recent study of an internet-based support ... for dieters on low-carbohydrate diets has been the addition ... carbohydrates removed from their diet. The report was published ...
... antibiotic shows early promise as an anti-cancer agent, inhibiting ... tumors, // according to researchers at the University of ... appear in the Oct. 1 issue of Cancer Research. ... to be over-expressed in cancer cells to screen for ...
Cached Medicine News:Health News:Awareness Must to Tackle Hepatitis: Experts 2Health News:Understanding Stress Triggers for African Americans 2Health News:Iraqi’s Gripped with Insecurit 2Health News:Iraqi’s Gripped with Insecurit 3Health News:Low-Carb Dieters Eat More Vegetables 2Health News:Antibiotic Inhibits Cancer Gene Activity 2
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
(Date:9/15/2014)... NEW YORK , Sept. 16, 2014 ... Neuropathy Foundation (HNF) announced today an agreement to collaborate ... disease and support the development of a stronger CMT ... provide financial support to several HNF,s initiatives including: ... section in the HNF website featuring  HNF newsletters, materials ...
(Date:9/15/2014)... , Sept. 15, 2014 /PRNewswire/ -  Pivotal Therapeutics ... specialty pharmaceutical company with a focus on Omega-3 ... today that the Board of Directors approved the ... an advisor at the close of business on Friday, ... of 1,000,000 common shares of the Company were ...
Breaking Medicine Technology:Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 2Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 3Pharnext and the Hereditary Neuropathy Foundation Collaborate to Increase Awareness of Charcot-Marie-Tooth Disease 4Pivotal Therapeutics Grants Incentive Stock Options 2
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 2FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 3FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 4FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 5FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 6FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 7FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 8FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 9FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 10FTC Bars Transitions Optical, Inc. from Using Anticompetitive Tactics to Maintain its Monopoly in Darkening Treatments for Eyeglass Lenses 11Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 2Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 3Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 4Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 5Rapid Review Imaging System From P&R Dental Strategies Assures Fast, Accurate and Efficient Dental Claim Review 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: